1-3 of 3
K Tebbi
Close
Sort by
Journal Articles

Long-Term Safety and Efficacy of Deferasirox (Exjade ® ) In Transfused Patients with Sickle Cell Disease Treated for up to 5 Years

Elliott Vichinsky, MD, Francoise Bernaudin, MD, Gian Luca Forni, MD, Renee Gardner, MD, Kathryn Hassell, MD, Matthew M. Heeney, MD, Baba Inusa, MD, Abdullah Kutlar, MD, Peter A. Lane, MD, Liesl Mathias, MD, John B. Porter, MD, Cameron K Tebbi, MD, Felicia L. Wilson, MD, Louis Griffel, MD, Wei Deng, PhD, Vanessa Giannone, BSN, Thomas D. Coates, MD
Journal: Blood
Blood (2010) 116 (21): 845.
https://doi.org/10.1182/blood.V116.21.845.845
Published: 2010
Journal Articles

Assessment of Safety and Efficacy of a New Intravenous Immunoglobulin (IGIV3I 10% Grifols) In Subjects with Chronic Immune Thrombocytopenia

Ali Khojasteh, MD, Giraldo Kato, Nehal Parikh, Tammuella Singleton, MD, Cameron K Tebbi, Caroline Cromwell, Chieh-Lin Fu, MD, Craig M. Kessler, MD, Jeffrey Letzer, DO, Bruce Ritchie, Charles Sexauer, Kapil Saxena, Surendra Sirpal, Marcela Torres, MD, Svetlana Loriya, MD, PhD, Lidia Kovaleva, MD, Virgilio Sandoval, MD, Miguel A. Sanz, MD, PhD, Antonio Julià, MD, Maria Montañés, Jordi Navarro
Journal: Blood
Blood (2010) 116 (21): 4669.
https://doi.org/10.1182/blood.V116.21.4669.4669
Published: 2010
Journal Articles

A comparison of granulopoiesis in culture from blood and marrow cells of nonleukemic individuals and patients with acute leukemia

K Tebbi, S Rubin, DH Cowan, EA McCulloch
Journal: Blood
Blood (1976) 48 (2): 235–243.
https://doi.org/10.1182/blood.V48.2.235.235
Published: 1976